Novel genetic and epigenetic alterations in ... - Ous-research.no
Novel genetic and epigenetic alterations in ... - Ous-research.no Novel genetic and epigenetic alterations in ... - Ous-research.no
Paper IVTerje Ahlquist, Ellen C Røyrvik, Marianne A Merok, Gunn I Meling,Annika Lindblom, Xiao-Feng Sun, Georgia Bardi, Matthias Kolberg,Arild Nesbakken and Ragnhild A Lothe.Identification of RCC2 as a prognostic marker among multiplegene mutations in colorectal cancer with defect mismatch repair.Manuscript
- Page 78 and 79: References133. Lind GE, Thorstensen
- Page 80 and 81: References156. Meling GI, Lothe RA,
- Page 82 and 83: ReferencesT, Song X, Day RH, Sledzi
- Page 84 and 85: References196. Honda S, Haruta M, S
- Page 86 and 87: ORIGINAL ARTICLESAPPENDIXAppendix I
- Page 89 and 90: GASTROENTEROLOGY 2007;132:1631-1639
- Page 91: Paper IbGuro E Lind, Terje Ahlquist
- Page 94 and 95: Journal of Translational Medicine 2
- Page 96 and 97: Journal of Translational Medicine 2
- Page 98 and 99: Journal of Translational Medicine 2
- Page 100 and 101: Journal of Translational Medicine 2
- Page 102 and 103: Journal of Translational Medicine 2
- Page 105: Paper IITerje Ahlquist, Guro E Lind
- Page 108 and 109: BackgroundMost cases of colorectal
- Page 110 and 111: ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
- Page 112 and 113: pseudogene, leading to a high rate
- Page 114 and 115: strands. Proc Natl Acad Sci U S A 1
- Page 116 and 117: concomitant absence of transcript a
- Page 119 and 120: Volume 10 Number 7 July 2008 pp. 68
- Page 121 and 122: 682 RAS Signaling in Colorectal Car
- Page 123 and 124: 684 RAS Signaling in Colorectal Car
- Page 125 and 126: 686 RAS Signaling in Colorectal Car
- Page 127: Table W2. Detailed Somatic Events o
- Page 132 and 133: ABSTRACTColorectal cancer (CRC) is
- Page 134 and 135: tumors it is hard to establish whic
- Page 136 and 137: embedded carcinomas was analyzed in
- Page 138 and 139: up with ExoSAP-IT (USB Corporation,
- Page 140 and 141: RESULTSMSI-analysisTumors with know
- Page 142 and 143: Figure 1. Mutation frequencies acro
- Page 144 and 145: Figure 3.Representativeelectrophero
- Page 146 and 147: ACVR2 ASTE1 CASP5 MARCKS MBD4 MRE11
- Page 148 and 149: DISCUSSIONColorectal cancer is a ve
- Page 150 and 151: had mutation frequencies of 75% or
- Page 152 and 153: Previous studies have shown that RC
- Page 154 and 155: REFERENCES1. Grady WM, Carethers JM
- Page 156 and 157: Studies on p53, BAX and Bcl-2 prote
- Page 158 and 159: Gene name Multiplex Annealing Numbe
- Page 161: Appendix I - List of abbreviations5
- Page 164 and 165: RØYRVIK ET AL.2plastic properties.
- Page 166 and 167: RØYRVIK ET AL.was, by reverse gene
- Page 168 and 169: RØYRVIK ET AL.the PubMed database;
- Page 170 and 171: RØYRVIK ET AL.TABLE I, continuedMu
- Page 172 and 173: RØYRVIK ET AL.TABLE I, continuedMu
- Page 174 and 175: RØYRVIK ET AL.gene must be validat
- Page 176 and 177: RØYRVIK ET AL.Another topic that d
Paper IVTerje Ahlquist, Ellen C Røyrvik, Marianne A Merok, Gunn I Mel<strong>in</strong>g,Annika L<strong>in</strong>dblom, Xiao-Feng Sun, Georgia Bardi, Matthias Kolberg,Arild Nesbakken <strong>and</strong> Ragnhild A Lothe.Identification of RCC2 as a prog<strong>no</strong>stic marker among multiplegene mutations <strong>in</strong> colorectal cancer with defect mismatch repair.Manuscript